Women's Cancer Research Foundation
Daily Aspirin Offers No Benefit in Breast Cancer Survivors
A recent study reported that daily intake of aspirin does not appear to prevent a recurrence of invasive breast cancer.
top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Search
bottom of page